[HTML][HTML] Understanding cachexia as a cancer metabolism syndrome

PE Porporato - Oncogenesis, 2016 - nature.com
Metabolic reprogramming occurs in tumors to foster cancer cell proliferation, survival and
metastasis, but as well at a systemic level affecting the whole organism, eventually leading …

The role of nitric oxide in tumour progression

D Fukumura, S Kashiwagi, RK Jain - Nature Reviews Cancer, 2006 - nature.com
Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumours and are
known to exert both pro-and anti-tumour effects. We summarize our current understanding of …

Regulation of inflammation in cancer by dietary eicosanoids

H Yang, E Rothenberger, T Zhao, W Fan, A Kelly… - Pharmacology & …, 2023 - Elsevier
Background Cancer is a major burden of disease worldwide and increasing evidence shows
that inflammation contributes to cancer development and progression. Eicosanoids are …

Therapy insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself

A Laviano, MM Meguid, A Inui, M Muscaritoli… - Nature clinical practice …, 2005 - nature.com
Tumor growth is associated with profound metabolic and neurochemical alterations, which
can lead to the onset of anorexia–cachexia syndrome. Anorexia is defined as the loss of the …

I. arginine

H Tapiero, G Mathé, P Couvreur, KD Tew - Biomedicine & …, 2002 - Elsevier
L-Arginine (Arg) is classified as an essential amino acid for birds, carnivores and young
mammals and a conditionally essential amino acid for adults. It is converted by arginase to L …

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

S Singh, AK Gupta - Cancer chemotherapy and pharmacology, 2011 - Springer
Purpose The diatomic radical nitric oxide (NO) has been the cause of intense debate with
implication in carcinogenesis, tumour progression, invasion, angiogenesis and modulation …

Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies

A Laviano, MM Meguid, F Rossi-Fanelli - The lancet oncology, 2003 - thelancet.com
Anorexia and reduced food intake are important issues in the management of patients with
cancer because they contribute to the development of malnutrition, increase morbidity and …

Understanding and managing cancer cachexia

N MacDonald, AM Easson, VC Mazurak… - Journal of the …, 2003 - journals.lww.com
Mrs MJ is a 56-year-old architect with a husband and two children. You performed a
mastectomy and axillary dissection on her after neoadjuvant chemotherapy for locally …

Expression of cyclooxygenase 2 in human malignant melanoma

C Denkert, M Köbel, S Berger, A Siegert, A Leclere… - Cancer research, 2001 - AACR
Abstract Cyclooxygenase (COX)-2 is an inducible enzyme involved in production of
prostaglandins in inflammatory processes. There is now increasing evidence that a …

[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma

DV Tudor, I Bâldea, M Lupu, T Kacso… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
With a constantly increasing incidence, cutaneous melanoma has raised the need for a
better understanding of its complex microenvironment that may further guide therapeutic …